IVD Medical has raised HK$1bn (US$131m) in its Hong Kong IPO after pricing at the bottom of the indicative price range. It has sold 333m shares, or 25% of the enlarged share capital, at the bottom of the HK$3.07-HK$3.68 range. The company is a distributor of in vitro diagnostic (IVD) products in China. It also…
©2023 All rights reserved LaingBuisson 
 in its Hong Kong IPO after pricing at the bottom of the indicative price range.){kind=link}